The share of Chinese scientific publications in the world's top 10% top-cited papers in immunology and microbiology is projected to rise steadily from 2024 to 2028. Based on the forecast data, China's share begins at 9.88% in 2024 and increases to 11.19% by 2028. In 2023, this share stood at 9.55%, indicating an annual growth rate trend for the subsequent years. Year-on-year percentage increases show a consistent upward trend, reflecting China's growing influence and contribution in this field. The projected compound annual growth rate (CAGR) over the coming five years further underscores this positive trajectory.
Future trends to watch for include China's investments in R&D, potential collaborations with international research bodies, and government policies supporting scientific advancements. Monitoring these factors can provide insights into the sustainability and potential acceleration of China's growth in top-cited scientific publications.
